v3.20.2
Consolidated Statements of Cash Flows - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
OPERATING ACTIVITIES          
Net loss $ (1,983,342) $ (4,724,647) $ (9,005,537) $ (4,122,133) $ (2,842,025)
Stock-based compensation-interest expense 1,085,371 3,243,812  
Stock-based compensation-product development costs 18,804 1,048,318 1,243,644 186,476 66,800
Stock-based compensation-professional fees 391,843 392,677 392,677 401,151 52,492
Stock-based compensation-general, selling and administration   805,865 1,244,636 993,716 80,938
Unpaid interest expense on line of credit     1,365,967 1,287,822 1,202,250
Non-cash imputed interest expense 60,737 60,856 122,488 122,183 154,848
Non-cash gain on reversal of expense     (86,236)
Accrued interest on line of credit 719,455 672,145
Changes in assets and liabilities:          
Decrease in prepaid expenses 1,429
Increase in accounts payable and accrued liabilities 83,595 48,507 128,813 13,725 95,106
Increase in interest payable 265,834 264,434 528,870 528,871 504,872
Net cash used in operating activities (443,074) (346,474) (734,630) (625,718) (769,526)
FINANCING ACTIVITIES          
Proceeds from borrowings on line of credit 441,948 346,819 733,090 625,986 770,030
Net cash provided by financing activities 441,948 346,819 733,090 625,986 770,030
Increase (decrease) in cash (1,126) 345 (1,540) 267 504
Cash, beginning of year 1,838 3,378 3,378 3,111 2,607
Cash, end of year $ 712 $ 3,723 $ 1,838 $ 3,378 $ 3,111